Trial Profile
DDAVP treatment combined with FVIII clotting factor concentrates in patients with mild haemophilia A.
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 04 Aug 2021
Price :
$35
*
At a glance
- Drugs Desmopressin (Primary) ; Moroctocog alfa (Primary) ; Octocog alfa (Primary) ; Turoctocog alfa (Primary)
- Indications Haemophilia A
- Focus Therapeutic Use
- Acronyms DAVID
- 17 Jun 2021 Results assessing accuracy, safety and FVIII concentrate savings of peri-operative pharmacokinetic (PK)-guided dosing of desmopressin combined with FVIII concentrate in non-severe hemophilia patients presented at the 26th Congress of the European Haematology Association
- 20 Jun 2016 New trial record